Axiom Corp (OTCMKTS:AXMM) has been making moves through its subsidiary Paper Nuts Corporation. Axiom owns 95.6% shares in Paper Nuts, which develops and markets innovative and environmentally friendly packaging solutions. Recently, Axiom made two major announcements regarding Paper Nuts. It has engaged SalesForce.com as its customer relationship management system. Additionally, the subsidiary has also completed the acquisitions of all intellectual properties owned by Deltapaper.
The agreement for the said acquisition was made in June, which states that Paper Nuts will acquire all rights to sell its products in North America, with complete ownership of its name, domain and patents. The company CEO, Tyler Pearson, stated that with the unified control over these intellectual properties, Paper Nuts can concentrate on its sales network and make use of its full potential.
Deltapaper on the other hand, is just as happy to be rid of those properties. The company now aims to focus its resources on strategic initiatives and opportunities, which are already under development. Deltapaper’s president, Jeff Bregman, stated that he believes that Paper Nuts and Axiom will keep working to grow the Paper Nuts product line and establish it as an environmentally friendly alternative for protective packaging.
Now that the company is looking towards potential growth, it is no wonder that it has employed the services of the world’s leading CRM, SalesForce. Mr. Pearson believes that this move will allow his company to build an effective and dynamic sales team. He also stated that by moving the sales department towards automation, his company can maximize their profits, increase business and generate and entirely new business.
SalesForce is a cloud based CRM, which uses innovative methods to establish a connection between client and customers. Mr. Pearson has had previous experience of using SalesForce, which has been quite positive. This is why he believes that the product is perfect for his company’s expansion.
Axiom Corp (OTCMKTS:AXMM) closed at $0.22, after losing 12.35% on May 18. The company has 66.15 million shares being traded in the market, with a 52-week range of $0.17-$1.87.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:
The Next Big Thing In Biotech?https://journaltranscript.com
Get our top rated alerts on the biotech sector
Miner Stock About To Explodehttps://www.journaltranscript.com
Investors are flocking to this stock like no tomorrow !
Traders Need To Know This Nowhttps://journaltranscript.com
WallStreet is loading up on this stock. Find out why